Rheabiotech is a high-tech start up founded in 2008 by university researchers and incubated in the State University of Campinas (Unicamp) in São Paulo, with a focus on developing immunochemical solutions for research and development.
Today the company has its own premises, including a 200 m2 laboratory in the heart of the university, technological and industrial ecosystem of Campinas, in the State of São Paulo.
Its research team includes doctoral and post-doctoral-level professionals, with the support of Unicamp and University of São Paulo (USP) professors.
Rheabiotech’s business model is articulated in three areas:
• The production of reagents for research and development: primary and secondary polyclonal and monoclonal antibodies, conjugated antibodies and recombinant proteins.
• The development of diagnostics kits for agricultural, veterinary and human health needs.
• Immunochemical services.
Apart from its own initiatives, the company works in partnership with universities and other research and development institutions, bridging the gap between fundamental research and the marketplace.
The company is fully equipped with all the necessary equipment and infrastructure to produce reagents and offer immunochemical services, complying with the official Biosecurity Quality Certification from CTNBio.
Mission: “Provide biotechnology solutions based on advanced research”
Rheabiotech develops its research and commercial activities according to stringent privacy and confidentiality standards as regards its employees, suppliers, service providers, researchers and customers. The proprietary information it handles is thoroughly protected and regulated by company charter.